Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.
Oncolab has raised $684K in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Oncolab's investors include FuturePlay.
Oncolab is headquartered in Cheongju, South Korea.
Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.
Oncolab is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncolab — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/oncolab. Accessed August 1, 2026.
VCBacked. (2025). Oncolab — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/oncolab
{{cite web |title=Oncolab — Funding & Investors |url=https://www.vcbacked.co/company/oncolab |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated